Global Drug-eluting Stent in Endoscopic Sinus Surgery 麻豆原创 Growth 2025-2031

Publication ID:

LPI08257475

Publication Date:

August 11, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Drug-eluting Stent in Endoscopic Sinus Surgery market size is predicted to grow from US$ 127 million in 2025 to US$ 179 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A drug-eluting stent used in endoscopic sinus surgery is a specialized medical device designed to maintain sinus patency after surgery while delivering localized, sustained-release medication鈥攖ypically corticosteroids鈥攖o reduce inflammation, minimize scarring, and prevent postoperative complications such as restenosis. These stents are bioabsorbable or non-absorbable and are placed in the sinus cavities during or after functional endoscopic sinus surgery (FESS) to improve healing outcomes.
United States market for Drug-eluting Stent in Endoscopic Sinus Surgery is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Drug-eluting Stent in Endoscopic Sinus Surgery is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Drug-eluting Stent in Endoscopic Sinus Surgery is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Drug-eluting Stent in Endoscopic Sinus Surgery players cover Intersect ENT, Stryker Corporation, Puyi (Shanghai) Biotechnology, Medtronic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淒rug-eluting Stent in Endoscopic Sinus Surgery Industry Forecast鈥� looks at past sales and reviews total world Drug-eluting Stent in Endoscopic Sinus Surgery sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug-eluting Stent in Endoscopic Sinus Surgery sales for 2025 through 2031. With Drug-eluting Stent in Endoscopic Sinus Surgery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-eluting Stent in Endoscopic Sinus Surgery industry.
This Insight Report provides a comprehensive analysis of the global Drug-eluting Stent in Endoscopic Sinus Surgery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug-eluting Stent in Endoscopic Sinus Surgery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Drug-eluting Stent in Endoscopic Sinus Surgery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-eluting Stent in Endoscopic Sinus Surgery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-eluting Stent in Endoscopic Sinus Surgery.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug-eluting Stent in Endoscopic Sinus Surgery market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Corticosteroids
Other
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Intersect ENT
Stryker Corporation
Puyi (Shanghai) Biotechnology
Medtronic
Key Questions Addressed in this Report
What is the 10-year outlook for the global Drug-eluting Stent in Endoscopic Sinus Surgery market?
What factors are driving Drug-eluting Stent in Endoscopic Sinus Surgery market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug-eluting Stent in Endoscopic Sinus Surgery market opportunities vary by end market size?
How does Drug-eluting Stent in Endoscopic Sinus Surgery break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Drug-eluting Stent in Endoscopic Sinus Surgery Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Drug-eluting Stent in Endoscopic Sinus Surgery by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Drug-eluting Stent in Endoscopic Sinus Surgery by Country/Region, 2020, 2024 & 2031
2.2 Drug-eluting Stent in Endoscopic Sinus Surgery Segment by Type
2.2.1 Corticosteroids
2.2.2 Other
2.3 Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Type
2.3.1 Global Drug-eluting Stent in Endoscopic Sinus Surgery Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Drug-eluting Stent in Endoscopic Sinus Surgery Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Drug-eluting Stent in Endoscopic Sinus Surgery Sale Price by Type (2020-2025)
2.4 Drug-eluting Stent in Endoscopic Sinus Surgery Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Application
2.5.1 Global Drug-eluting Stent in Endoscopic Sinus Surgery Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Drug-eluting Stent in Endoscopic Sinus Surgery Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Drug-eluting Stent in Endoscopic Sinus Surgery Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Drug-eluting Stent in Endoscopic Sinus Surgery Breakdown Data by Company
3.1.1 Global Drug-eluting Stent in Endoscopic Sinus Surgery Annual Sales by Company (2020-2025)
3.1.2 Global Drug-eluting Stent in Endoscopic Sinus Surgery Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Drug-eluting Stent in Endoscopic Sinus Surgery Annual Revenue by Company (2020-2025)
3.2.1 Global Drug-eluting Stent in Endoscopic Sinus Surgery Revenue by Company (2020-2025)
3.2.2 Global Drug-eluting Stent in Endoscopic Sinus Surgery Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Drug-eluting Stent in Endoscopic Sinus Surgery Sale Price by Company
3.4 Key Manufacturers Drug-eluting Stent in Endoscopic Sinus Surgery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-eluting Stent in Endoscopic Sinus Surgery Product Location Distribution
3.4.2 Players Drug-eluting Stent in Endoscopic Sinus Surgery Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Drug-eluting Stent in Endoscopic Sinus Surgery by Geographic Region
4.1 World Historic Drug-eluting Stent in Endoscopic Sinus Surgery 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Drug-eluting Stent in Endoscopic Sinus Surgery Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Drug-eluting Stent in Endoscopic Sinus Surgery Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Drug-eluting Stent in Endoscopic Sinus Surgery 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Drug-eluting Stent in Endoscopic Sinus Surgery Annual Sales by Country/Region (2020-2025)
4.2.2 Global Drug-eluting Stent in Endoscopic Sinus Surgery Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drug-eluting Stent in Endoscopic Sinus Surgery Sales Growth
4.4 APAC Drug-eluting Stent in Endoscopic Sinus Surgery Sales Growth
4.5 Europe Drug-eluting Stent in Endoscopic Sinus Surgery Sales Growth
4.6 Middle East & Africa Drug-eluting Stent in Endoscopic Sinus Surgery Sales Growth
5 Americas
5.1 Americas Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Country
5.1.1 Americas Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Country (2020-2025)
5.1.2 Americas Drug-eluting Stent in Endoscopic Sinus Surgery Revenue by Country (2020-2025)
5.2 Americas Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Type (2020-2025)
5.3 Americas Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Region
6.1.1 APAC Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Region (2020-2025)
6.1.2 APAC Drug-eluting Stent in Endoscopic Sinus Surgery Revenue by Region (2020-2025)
6.2 APAC Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Type (2020-2025)
6.3 APAC Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Drug-eluting Stent in Endoscopic Sinus Surgery by Country
7.1.1 Europe Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Country (2020-2025)
7.1.2 Europe Drug-eluting Stent in Endoscopic Sinus Surgery Revenue by Country (2020-2025)
7.2 Europe Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Type (2020-2025)
7.3 Europe Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug-eluting Stent in Endoscopic Sinus Surgery by Country
8.1.1 Middle East & Africa Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Country (2020-2025)
8.1.2 Middle East & Africa Drug-eluting Stent in Endoscopic Sinus Surgery Revenue by Country (2020-2025)
8.2 Middle East & Africa Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Type (2020-2025)
8.3 Middle East & Africa Drug-eluting Stent in Endoscopic Sinus Surgery Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-eluting Stent in Endoscopic Sinus Surgery
10.3 Manufacturing Process Analysis of Drug-eluting Stent in Endoscopic Sinus Surgery
10.4 Industry Chain Structure of Drug-eluting Stent in Endoscopic Sinus Surgery
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-eluting Stent in Endoscopic Sinus Surgery Distributors
11.3 Drug-eluting Stent in Endoscopic Sinus Surgery Customer
12 World Forecast Review for Drug-eluting Stent in Endoscopic Sinus Surgery by Geographic Region
12.1 Global Drug-eluting Stent in Endoscopic Sinus Surgery 麻豆原创 Size Forecast by Region
12.1.1 Global Drug-eluting Stent in Endoscopic Sinus Surgery Forecast by Region (2026-2031)
12.1.2 Global Drug-eluting Stent in Endoscopic Sinus Surgery Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Drug-eluting Stent in Endoscopic Sinus Surgery Forecast by Type (2026-2031)
12.7 Global Drug-eluting Stent in Endoscopic Sinus Surgery Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Intersect ENT
13.1.1 Intersect ENT Company Information
13.1.2 Intersect ENT Drug-eluting Stent in Endoscopic Sinus Surgery Product Portfolios and Specifications
13.1.3 Intersect ENT Drug-eluting Stent in Endoscopic Sinus Surgery Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Intersect ENT Main Business Overview
13.1.5 Intersect ENT Latest Developments
13.2 Stryker Corporation
13.2.1 Stryker Corporation Company Information
13.2.2 Stryker Corporation Drug-eluting Stent in Endoscopic Sinus Surgery Product Portfolios and Specifications
13.2.3 Stryker Corporation Drug-eluting Stent in Endoscopic Sinus Surgery Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Stryker Corporation Main Business Overview
13.2.5 Stryker Corporation Latest Developments
13.3 Puyi (Shanghai) Biotechnology
13.3.1 Puyi (Shanghai) Biotechnology Company Information
13.3.2 Puyi (Shanghai) Biotechnology Drug-eluting Stent in Endoscopic Sinus Surgery Product Portfolios and Specifications
13.3.3 Puyi (Shanghai) Biotechnology Drug-eluting Stent in Endoscopic Sinus Surgery Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Puyi (Shanghai) Biotechnology Main Business Overview
13.3.5 Puyi (Shanghai) Biotechnology Latest Developments
13.4 Medtronic
13.4.1 Medtronic Company Information
13.4.2 Medtronic Drug-eluting Stent in Endoscopic Sinus Surgery Product Portfolios and Specifications
13.4.3 Medtronic Drug-eluting Stent in Endoscopic Sinus Surgery Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Medtronic Main Business Overview
13.4.5 Medtronic Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.